Header Image
22. Chronic pain / muscle tension in ADHD

Sitemap

22. Chronic pain / muscle tension in ADHD

Author: Ulrich Brennecke
Review (March 2024): Dipl.-Psych. Waldemar Zdero
Completely revised: December 2024

1. Chronic pain and ADHD

People with ADHD often show increased sensitivity to pain. High ADHD scores correlated with increased pain1
Chronic pain and pain intensity in patients with ADHD are associated with muscular dysregulation.2

In children with chronic pain (without headaches) an ADHD prevalence of 15 to 25 %, i.e. 2 to 5 times higher (meta-analysis).3
72.5% of adults referred to a pain clinic for chronic pain and a probable somatic syndrome disorder met the diagnostic criteria for ADHD.4 Of 60 adults with chronic non-specific lower back pain, 31.5% had ADHD.5
Psychiatric patients with chronic pain show a higher prevalence of ADHD than psychiatric patients without chronic pain.2
Children with ADHD showed a prevalence of chronic pain of up to 66% (at least weekly pain for more than 3 months). Stimulant treatment reduced the rate of chronic pain. Another study found a reduced perception of pain in adolescents with ADHD, which disappeared with stimulant treatment.3
Of young women with ADHD and/or ASD, 76.6%6 and 75.9% reported chronic pain, respectively, compared to 45.7% of unaffected young women7.
80% of the people with ADHD studied reported chronic pain at .8

One study found ADHD in 25 of 30 patients with refractory orofacial pain (83.3%; women: 20).9
ADHD was associated with a 32% increased risk of migraine, while the risk of tension headaches was unchanged.1011 Children with migraine had a 2.6-fold risk of ADHD, while the prevalence of migraine in children in general was 3.76%. Migraines correlated particularly with hyperactivity and impulsivity, not inattention.12 Children with ADHD have a 2.6-fold risk of migraine in ADHD, whereas the prevalence of migraine in children in general was 9.9% in this study11

2. Axial pain and ADHD

Chronic pain in patients with ADHD is characterized by widespread and axial pain that starts early. This “ADHD pain” is qualitatively different from chronic pain in patients without ADHD.2
Axial pain occurred in 86.6% of persons with ADHD, in 50% of those not diagnosed with ADHD, and in 21.4% of those who also did not have subclinical ADHD.
People with subclinical ADHD showed the same muscular dysregulation as people with ADHD.2
While ADHD is a predictor of “axial pain”, affective disorders, anxiety disorders or personality disorders were not.2

The axial muscles are:

  • Head and neck muscles
  • Spinal muscles
  • Other trunk muscles
  • Pelvic floor muscles

Axial muscles regulate and control posture and are constantly used to maintain the naturally unstable upright position. Muscular dysregulation has a significant impact here and could lead to high muscle tone with consequent widespread pain and lower back pain13

  • Erector spinae
  • Latissimus dorsi
  • Iliopsoas
    • connects the lumbar spine with the lower limbs
    • Iliopsoas spasms can increase lumbar lordosis and lumbar pain14

Gene variants that correlate with neck or shoulder pain causally increase the risk of ADHD.15

3. Increased muscle tension in ADHD

ADHD is often associated with increased muscle tension. This is not an expression of hyperactivity or a fundamental motor dysfunction. There are high-performance athletes with ADHD; they are unlikely to have severe motor dysfunction. Nevertheless, increased muscle tension can also be observed in them.

Muscle tension, especially in the shoulder/neck area, occurs much more frequently with ADHD.
So far, we have been unable to find a plausible neurophysiological explanation for this.
An orthopaedist explained to us that during sleep, the muscles further away from the trunk (spine) relax first, while those on the spine relax last. These need undisturbed deep sleep in order to relax. Accordingly, muscle tension could also be a consequence of impaired sleep in ADHD.

With regard to fibromyalgia, which is often associated with greatly increased muscle tension, helpful treatment with very low-dose naltrexone is reported (0.5 to 4.5 mg instead of the usual 150 mg). The treatment is said to be virtually free of side effects.1617181920 Naltrexone is a long-acting competitive opioid antagonist that is also used to treat alcohol and opioid dependence. One person with ADHD told us that the low-dose naltrexone also helped with the ADHD symptoms.
Paracetamol was repeatedly mentioned as a treatment option.
Magnesium is also helpful.
Myotonolytics (e.g. methocarbamol, tolperisone, tetrazepam, flupirtine, tizanidine, baclofen, pridinol, eperisone or methocarbamol) have a muscle-relaxing effect by inhibiting polysynaptic reflex conduction in the spinal cord and in subcortical centers. However, they are less suitable for long-term use and have significant side effects. Tizanidine and cyclobenzaprine have a sedative effect and can help with existing sleep problems.21 Methocarbamol and metaxalone are slightly less sedating, but probably also less effective. Dizziness and drowsiness are reported with all myotonolytics.

4. Causal pathways for chronic pain, increased muscle tone and fibromyalgia

According to Stray, motor disinhibition and increased muscle tone in ADHD are directly associated with dysregulation of the dopamine and noradrenaline systems.22
It is fitting that the increased muscle tone in ADHD is reduced by methylphenidate23 and that a noradrenaline reuptake inhibitor (orphenadrine, Norflex®) serves as a skeletal muscle relaxant. Noradrenaline reuptake inhibitors are also used as ADHD medication (atomoxetine, viloxazine).

One study reports an increased sphingomyelin/ceramide ratio in patients with lower back pain24 (which is also a typical form of ADHD). The acid sphingomyelinase (ASM, sphingomyelin phosphodiesterase 1, encoded by the ADHD candidate gene SMPD1) Degrades sphingomyelin to ceramide. If sphingomyelin is high and ceramide is low, this indicates weak S-ASM. With this in mind, FIASMA (ASM inhibitors) could be detrimental and increase the risk of muscle tension. Whether this idea is supportive for ADHD remains to be seen

See also Chronic pain and muscle tension in ADHD - neurophysiological correlates


  1. Stickley, Koyanagi, Takahashi, Kamio (2016): ADHD symptoms and pain among adults in England. Psychiatry Res. 2016 Dec 30;246:326-331. doi: 10.1016/j.psychres.2016.10.004.

  2. Udal ABH, Stray LL, Stray T, Bertelsen TB, Pripp AH, Egeland J (2024): ADHD-pain: Characteristics of chronic pain and association with muscular dysregulation in adults with ADHD. Scand J Pain. 2024 Sep 9;24(1). doi: 10.1515/sjpain-2024-0015. PMID: 39253953.

  3. Battison EAJ, Brown PCM, Holley AL, Wilson AC (2023): Associations between Chronic Pain and Attention-Deficit Hyperactivity Disorder (ADHD) in Youth: A Scoping Review. Children (Basel). 2023 Jan 11;10(1):142. doi: 10.3390/children10010142. PMID: 36670692; PMCID: PMC9857366. REVIEW

  4. Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Yamada Y (2020): Attention-Deficit/Hyperactivity Disorder and Chronic Pain. Psychosom Med. 2020 Apr;82(3):346-347. doi: 10.1097/PSY.0000000000000789. PMID: 32251099.

  5. Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Fujii T, Konno SI, Kikuchi SI, Yamada Y (2021): High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain. Pain Physician. 2021 May;24(3):E299-E307. PMID: 33988951.

  6. Asztély, Kopp, Gillberg, Waern, Bergman (2019): Chronic Pain And Health-Related Quality Of Life In Women With Autism And/Or ADHD: A Prospective Longitudinal Study. J Pain Res. 2019 Oct 18;12:2925-2932. doi: 10.2147/JPR.S212422. eCollection 2019.

  7. Mundal I, Schei J, Lydersen S, Thomsen PH, Nøvik TS, Kvitland LR (2024): Prevalence of chronic and multisite pain in adolescents and young adults with ADHD: a comparative study between clinical and general population samples (the HUNT study). Eur Child Adolesc Psychiatry. 2024 May;33(5):1433-1442. doi: 10.1007/s00787-023-02249-x. PMID: 37386203; PMCID: PMC11098922.

  8. Stray, Kristensen, Lomeland, Skorstad, Stray, Tønnessen (2013): Motor regulation problems and pain in adults diagnosed with ADHD. Behav Brain Funct. 2013 May 3;9:18. doi: 10.1186/1744-9081-9-18. PMID: 23642255; PMCID: PMC3652792.

  9. Kasahara S, Takahashi K, Matsudaira K, Sato N, Fukuda KI, Toyofuku A, Yoshikawa T, Kato Y, Niwa SI, Uchida K (2023): Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder. Sci Rep. 2023 Jan 30;13(1):1678. doi: 10.1038/s41598-023-28931-3. PMID: 36717626; PMCID: PMC9887013.

  10. Salem H, Vivas D, Cao F, Kazimi IF, Teixeira AL, Zeni CP (2018): ADHD is associated with migraine: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):267-277. doi: 10.1007/s00787-017-1045-4. PMID: 28905127. REVIEW

  11. Arruda MA, Arruda R, Guidetti V, Bigal ME (2020): ADHD Is Comorbid to Migraine in Childhood: A Population-Based Study. J Atten Disord. 2020 May;24(7):990-1001. doi: 10.1177/1087054717710767. PMID: 28587507.

  12. Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME (2010): Migraine, tension-type headache, and attention-deficit/hyperactivity disorder in childhood: a population-based study. Postgrad Med. 2010 Sep;122(5):18-26. doi: 10.3810/pgm.2010.09.2197. PMID: 20861584.

  13. Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Fujii T, Konno SI, Kikuchi SI, Yamada Y (2021): High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain. Pain Physician. 2021 May;24(3):E299-E307. PMID: 33988951.}}) erklären in{{Udal ABH, Stray LL, Stray T, Bertelsen TB, Pripp AH, Egeland J (2024): ADHD-pain: Characteristics of chronic pain and association with muscular dysregulation in adults with ADHD. Scand J Pain. 2024 Sep 9;24(1). doi: 10.1515/sjpain-2024-0015. PMID: 39253953.

  14. Lakkadsha TM, Qureshi MI, Kovela RK, Saifee SS, Lalwani SS (2022): Efficacy of Single Stretching Session of Iliopsoas Using Proprioceptive Neuromuscular Facilitation Versus Muscle Energy Technique on Low Back Pain in Patients With Lumbar Hyper-Lordosis. Cureus. 2022 Aug 12;14(8):e27916. doi: 10.7759/cureus.27916. PMID: 36110466; PMCID: PMC9464355.

  15. García-Marín, Campos, Cuéllar-Partida, Medland, Kollins, Rentería (2021): Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Sci Rep. 2021 Nov 19;11(1):22628. doi: 10.1038/s41598-021-01517-7. PMID: 34799595.

  16. Überall, M A, Maurer S. (2023): Niedrig dosiertes Naltrexon zur Behandlung der Fibromyalgie: Vom Paradoxon eines Opioidantagonisten in der Schmerztherapie. Schmerzmedizin, 39(3), 46–49. https://doi.org/10.1007/s00940-023-4162-9

  17. Yang J, Shin KM, Do A, Bierle DM, Abu Dabrh AM, Yin Z, Bauer BA, Mohabbat AB (2023): The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review. J Pain Res. 2023 Mar 21;16:1017-1023. doi: 10.2147/JPR.S395457. PMID: 36974308; PMCID: PMC10039621. METASTUDY, k = 9

  18. Vatvani AD, Patel P, Hariyanto TI, Yanto TA (2024): Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Korean J Pain. 2024 Oct 1;37(4):367-378. doi: 10.3344/kjp.24202. PMID: 39344363; PMCID: PMC11450306. METASTUDY, k = 4

  19. Partridge S, Quadt L, Bolton M, Eccles J, Thompson C, Colasanti A, Bremner S, Jones CI, Bruun KD, Van Marwijk H (2023): A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. Heliyon. 2023 Apr 19;9(5):e15638. doi: 10.1016/j.heliyon.2023.e15638. PMID: 37206027; PMCID: PMC10189400. REVIEW

  20. Rassi-Mariani V, Barreto ESR, Antunes CR, Alencar VB, Falcão Lins-Kusterer LE, Azi LMTA, Kraychete DC (2024): The use of naltrexone in the treatment of chronic pain: a systematic review. Pain Manag. 2024;14(8):453-463. doi: 10.1080/17581869.2024.2401769. PMID: 39301937; PMCID: PMC11487945.

  21. See S, Ginzburg R (2008): Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70. PMID: 18711953. REVIEW

  22. Stray (2009): Motor problems in Children with ADHD and clinical effects of Methylphenidate as assessed with the MFNU. Dissertation.

  23. Stray, Stray, Iversen, Ruud, Ellertsen (2009): Methylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder. Behav Brain Funct. 2009 May 13;5:21. doi: 10.1186/1744-9081-5-21. PMID: 19439096; PMCID: PMC2686715.

  24. Zhang Z, Zhang C, Li Y, Wang C, Yu Q (2022): Lipid and metabolic alteration involvement in physiotherapy for chronic nonspecific low back pain. Lipids Health Dis. 2022 Nov 25;21(1):125. doi: 10.1186/s12944-022-01737-4. PMID: 36434687; PMCID: PMC9700977.

Diese Seite wurde am 18.06.2025 zuletzt aktualisiert.